相似文献
1
HIV-1 envelope glycoprotein structure.
Curr Opin Struct Biol. 2013 Apr;23(2):268-76. doi: 10.1016/j.sbi.2013.03.007. Epub 2013 Apr 18.
2
Conformational Differences between Functional Human Immunodeficiency Virus Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.01709-18. Print 2019 Feb 1.
3
Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.00175-17. Print 2017 May 15.
4
Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer.
Nat Struct Mol Biol. 2012 Sep;19(9):893-9. doi: 10.1038/nsmb.2351. Epub 2012 Aug 5.
5
Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7151-E7158. doi: 10.1073/pnas.1615939113. Epub 2016 Oct 31.
6
Crystal structure of a soluble cleaved HIV-1 envelope trimer.
Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31.
7
The membrane-proximal external region of human immunodeficiency virus (HIV-1) envelope glycoprotein trimers in A18-lipid nanodiscs.
Commun Biol. 2025 Mar 15;8(1):442. doi: 10.1038/s42003-025-07852-z.
8
X-ray and EM structures of a natively glycosylated HIV-1 envelope trimer.
Acta Crystallogr D Struct Biol. 2017 Oct 1;73(Pt 10):822-828. doi: 10.1107/S2059798317013353. Epub 2017 Sep 29.
9
Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.
J Virol. 2021 Nov 23;95(24):e0052921. doi: 10.1128/JVI.00529-21. Epub 2021 Sep 22.
10
Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
J Biol Chem. 2005 Jun 17;280(24):23138-46. doi: 10.1074/jbc.M414515200. Epub 2005 Apr 15.
引用本文的文献
1
30 years of HIV therapy: Current and future antiviral drug targets.
Virology. 2025 Feb;603:110362. doi: 10.1016/j.virol.2024.110362. Epub 2024 Dec 17.
2
New insights into protein-protein interaction modulators in drug discovery and therapeutic advance.
Signal Transduct Target Ther. 2024 Dec 6;9(1):341. doi: 10.1038/s41392-024-02036-3.
3
Microsecond dynamics control the HIV-1 Envelope conformation.
Sci Adv. 2024 Feb 2;10(5):eadj0396. doi: 10.1126/sciadv.adj0396.
4
Physico-Chemical Mechanisms of the Functioning of Membrane-Active Proteins of Enveloped Viruses.
Biochem (Mosc) Suppl Ser A Membr Cell Biol. 2022;16(4):247-260. doi: 10.1134/S1990747822050038. Epub 2022 Dec 9.
5
Membrane attachment and fusion of HIV-1, influenza A, and SARS-CoV-2: resolving the mechanisms with biophysical methods.
Biophys Rev. 2022 Oct 11;14(5):1109-1140. doi: 10.1007/s12551-022-00999-7. eCollection 2022 Oct.
6
Comparing methods for immobilizing HIV-1 SOSIPs in ELISAs that evaluate antibody binding.
Sci Rep. 2022 Jul 1;12(1):11172. doi: 10.1038/s41598-022-15506-x.
7
Evolution of Antibodies to Native Trimeric Envelope and Their Fc-Dependent Functions in Untreated and Treated Primary HIV Infection.
J Virol. 2021 Nov 23;95(24):e0162521. doi: 10.1128/JVI.01625-21. Epub 2021 Sep 29.
8
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses.
Future Microbiol. 2021 Sep;16(14):1105-1133. doi: 10.2217/fmb-2021-0064. Epub 2021 Sep 1.
9
Deep Mutational Scanning of Viral Glycoproteins and Their Host Receptors.
Front Mol Biosci. 2021 Apr 9;8:636660. doi: 10.3389/fmolb.2021.636660. eCollection 2021.
10
Structure, membrane topology and influence of cholesterol of the membrane proximal region: transmembrane helical anchor sequence of gp41 from HIV.
Sci Rep. 2020 Dec 17;10(1):22278. doi: 10.1038/s41598-020-79327-6.
本文引用的文献
1
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies.
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4592-7. doi: 10.1073/pnas.1214913110. Epub 2013 Mar 4.
2
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.
Immunity. 2013 Jan 24;38(1):176-86. doi: 10.1016/j.immuni.2012.11.011. Epub 2013 Jan 11.
3
The potent human immunodeficiency virus type 1 (HIV-1) entry inhibitor HR212 blocks formation of the envelope glycoprotein gp41 six-helix bundle.
AIDS Res Hum Retroviruses. 2013 Mar;29(3):613-20. doi: 10.1089/aid.2012.0059. Epub 2013 Jan 11.
4
Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives.
Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):513-8. doi: 10.1073/pnas.1214810110. Epub 2012 Dec 24.
5
Protein secondary structure determination by constrained single-particle cryo-electron tomography.
Structure. 2012 Dec 5;20(12):2003-13. doi: 10.1016/j.str.2012.10.016.
6
Cryo-electron microscopy--a primer for the non-microscopist.
FEBS J. 2013 Jan;280(1):28-45. doi: 10.1111/febs.12078. Epub 2012 Dec 17.
7
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.
Nature. 2012 Nov 15;491(7424):406-12. doi: 10.1038/nature11544. Epub 2012 Sep 18.
8
A collaborative framework for 3D alignment and classification of heterogeneous subvolumes in cryo-electron tomography.
J Struct Biol. 2013 Feb;181(2):116-27. doi: 10.1016/j.jsb.2012.10.010. Epub 2012 Oct 27.
9
HIV entry and envelope glycoprotein-mediated fusion.
J Biol Chem. 2012 Nov 30;287(49):40841-9. doi: 10.1074/jbc.R112.406272. Epub 2012 Oct 5.
10
HIV: cell binding and entry.
Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a006866. doi: 10.1101/cshperspect.a006866.
Zotero 插件